These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 369645)

  • 21. [Vitality evaluation of malignant melanoma metastases following endolymphatic radionuclide therapy using the Falck-Hillarp method].
    Paul E; Illig L; Möller W
    Hautarzt; 1975 Jun; 26(6):317-20. PubMed ID: 1165195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralymphatic steroid therapy for lymphoedema: preliminary studies.
    Fyfe NC; Rutt DL; Edwards JM; Kinmonth JB
    Lymphology; 1982 Mar; 15(1):23-8. PubMed ID: 7070113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endolymphatic therapy for malignant melanoma.
    Edwards JM; Kinmonth JB
    Br Med J; 1968 Jan; 1(5583):18-22. PubMed ID: 4295232
    [No Abstract]   [Full Text] [Related]  

  • 24. Endolymphatic radionuclide therapy.
    Kubícek J; Vizda J; Urbanová E; Morávek F
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1979; 22(2):101-14. PubMed ID: 293870
    [No Abstract]   [Full Text] [Related]  

  • 25. [Follow-up studies in endolymphatic radioisotope therapy].
    Wolf G
    Strahlentherapie; 1971 Sep; 142(3):269-75. PubMed ID: 5118494
    [No Abstract]   [Full Text] [Related]  

  • 26. [Value of lymphoscintigraphy in the indication for and progress control of endolymphatic therapy].
    Döge H; Hennig K; Franke WG; Köhler K
    Z Gesamte Inn Med; 1972 Nov; 27(21):913-8. PubMed ID: 4123115
    [No Abstract]   [Full Text] [Related]  

  • 27. Malignant melanoma: treatment by endolymphatic radio-isotope infusion.
    Edwards JM
    Ann R Coll Surg Engl; 1969 May; 44(5):237-54. PubMed ID: 4306320
    [No Abstract]   [Full Text] [Related]  

  • 28. [Endolymphatic lipiodol-P32 therapy in melanoma of the limbs during clinical stage 1].
    Kokoschka E
    Med Welt; 1974 Jun; 25(23):1054-5. PubMed ID: 4369551
    [No Abstract]   [Full Text] [Related]  

  • 29. [Indications for and borderlines of endolymphatic therapy of melanoma and seminoma].
    Kärcher KH; Messeritsch M; Bardach G; Seitz W; Wolf G
    Strahlentherapie Sonderb; 1972; 72():261-72. PubMed ID: 4659340
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.
    Spitler LE; Sagebiel R
    N Engl J Med; 1980 Nov; 303(20):1143-7. PubMed ID: 6999349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma.
    Kissin MW; Simpson DA; Easton D; White H; Westbury G
    Br J Surg; 1987 Nov; 74(11):1023-6. PubMed ID: 3690228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endolymphatic infusion: human surgical investigation and application.
    Petrov S
    Lymphat Res Biol; 2003; 1(1):75-9; discussion 79-80. PubMed ID: 15624325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radiation-dosimetry studies after endolymphatic radionuclide therapy].
    Pfannenstiel P
    Med Welt; 1974 Jun; 25(23):1038-42. PubMed ID: 4369658
    [No Abstract]   [Full Text] [Related]  

  • 34. [Endolymphatic use of solutions of alkylating substances in a mixture with iodolipol in malignant neoplasms].
    Lytkin GV
    Vopr Onkol; 1981; 27(7):35-9. PubMed ID: 6168108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difficulty in clinical assessment of lymph-nodes after endolymphatic radio-iodine.
    Blake J
    Postgrad Med J; 1968 Apr; 44(510):336-8. PubMed ID: 5649397
    [No Abstract]   [Full Text] [Related]  

  • 36. Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities.
    Ariyan S; Kirkwood JM; Mitchell MS; Nordlund JJ; Lerner AB; Papac RJ
    Surgery; 1982 Sep; 92(3):459-63. PubMed ID: 7112396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Scintigraphic examinations of the lymph before endolymphatic radionuclide therapy of the malignant melanoma of the inferior extremity (author's transl)].
    Müller RP; Vosberg H; Peters PE; Hemmelskamp S
    Strahlentherapie; 1979 Apr; 155(4):243-7. PubMed ID: 452049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Indication and preliminary results of endolymphatic radioisotope therapy in malignant diseases of the lymphatic system].
    Strickstrock KH; Weissleder H; Pfannenstiel P; Afkham IK; Hoffmann G; Musshoff K
    Strahlentherapie Sonderb; 1969; 69():197-210. PubMed ID: 5778905
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevention and treatment of regional lymphatic metastasis of cutaneous melanoma].
    Korovin SI; Tolstopiatov BA
    Klin Khir (1962); 1993; (5):34-6. PubMed ID: 7933861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence and survival after neck dissections in cutaneous head and neck melanoma.
    Andersen PS; Chakera AH; Thamsborg AK; Kølle SF; Schmidt G; Klyver H; Drzewiecki KT
    Dan Med J; 2014 Dec; 61(12):A4953. PubMed ID: 25441725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.